Company News: StrikeForce Communications and Makovsky + Co.

Share this article:
Alcon has awarded two accounts to StrikeForce Communications, including global strategic and creative responsibilities for I-Caps, a line of ocular nutrition products aimed at delaying the progress of age related macular degeneration, and for OTC dry eye therapy Systane. The New York-based shop also recently won an assignment for Orexigen Theraeutics' obesity drug, which is under FDA review.

Makovsky + Company has been retained by Neoprobe Corp., for its strategic communications and investor relations program as the Dublin, Ohio-based firm, which makes surgical oncology products, prepares for the commercialization of Lymphoseek and the launch of a RIGS clinical development program.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions